- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05020795
Effect of Proximal Blood Flow Arrest During Endovascular Thrombectomy (ProFATE)
June 23, 2025 updated by: Nottingham University Hospitals NHS Trust
Endovascular thrombectomy (EVT) has become the standard of care for large vessel occlusion in acute ischaemic stroke (AIS).
During clot-retrieval, simultaneous balloon inflation within the internal carotid artery offers transient proximal blood flow arrest, potentially preventing distal clot migration or embolisation to new vascular territories.
Retrospective studies indicate that this may improve complete vessel recanalisation rates and may translate to improved functional independence.
However, lack of high-quality evidence demonstrating the efficacy of simultaneous balloon inflation has led to clinical equipoise with heterogeneity of practice globally.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
134
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Nottingham, United Kingdom, NG7 2UH
- Nottingham University Hospitals Nhs Trust
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Age ≥18 years
- Acute ischemic stroke presenting with a neurological deficit of (NIHSS ≥2)
- Intracranial arterial occlusion of the distal internal carotid artery or middle cerebral artery (M1/M2 segments) demonstrated with on clinical neuroimaging such as: computed tomography angiogram (CTA), magnetic resonance imaging angiogram (MRA), or digital subtraction angiography (DSA).
- ASPECTS score of >4 or by locally accepted ischaemic core/penumbra mismatch using computed tomography perfusion or magnetic resonance (CTP or MR) imaging.
- modified Rankin Scale, mRS<3
- Intention to treat with aspiration only or combination technique of stent-retriever + aspiration in the first pass attempt during endovascular thrombectomy
Exclusion Criteria:
- Severe stenosis (>90%), or tandem occlusion of the ipsilateral extracranial internal carotid artery.
- Previously deployed stents in the ipsilateral internal carotid artery.
- Dissections of the ipsilateral internal carotid artery.
- Unlikely to be available for 90 days follow-up (e.g. no fixed home address, visitor from overseas).
- Subject participating in a study involving an investigational drug or device that would impact this study.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Balloon inflation
Endovascular thrombectomy with simultaneous balloon inflation using a balloon guide catheter
|
Clot retrieval for large vessel occlusion in acute ischaemic stroke
|
|
Active Comparator: No balloon inflation
Endovascular thrombectomy without simultaneous balloon inflation using a balloon guide catheter
|
Clot retrieval for large vessel occlusion in acute ischaemic stroke
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Modified thrombolysis in cerebral infarction (mTICI) score of 2c-3
Time Frame: Immediately after endovascular thrombectomy
|
Near complete-complete vessel recanalisation
|
Immediately after endovascular thrombectomy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mortality
Time Frame: 90 days
|
90 days
|
|
|
Modified thrombolysis in cerebral infarction (mTICI) score of 2b-3
Time Frame: Immediately after endovascular thrombectomy
|
Successful vessel recanalisation
|
Immediately after endovascular thrombectomy
|
|
First pass effect (mTICI2c-3)
Time Frame: During endovascular thrombectomy procedure
|
Near complete-complete vessel recanalisation after the first pass attempt at clot retrieval
|
During endovascular thrombectomy procedure
|
|
New or distal vascular territory clot embolisation
Time Frame: Immediately after endovascular thrombectomy
|
Immediately after endovascular thrombectomy
|
|
|
Modified Rankin Scale 0-2
Time Frame: 90 days
|
Good functional outcome based on the modified Rankin scale of disability
|
90 days
|
|
Symptomatic intracranial haemorrhage
Time Frame: 24 hours after Endovascular thrombectomy
|
24 hours after Endovascular thrombectomy
|
|
|
National Institutes of Health of Stroke Scale (NIHSS)
Time Frame: 24 hours
|
Change in stroke severity
|
24 hours
|
|
Total number of passes at clot retrieval
Time Frame: Immediately after endovascular thrombectomy
|
Immediately after endovascular thrombectomy
|
|
|
Procedure related complications
Time Frame: Immediately after endovascular thrombectomy
|
Immediately after endovascular thrombectomy
|
|
|
Total procedural time
Time Frame: Immediately after endovascular thrombectomy
|
Immediately after endovascular thrombectomy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Permesh Singh Dhillon, Nottingham University Hospitals Nhs Trust
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
October 7, 2021
Primary Completion (Actual)
October 1, 2023
Study Completion (Actual)
November 1, 2023
Study Registration Dates
First Submitted
August 20, 2021
First Submitted That Met QC Criteria
August 24, 2021
First Posted (Actual)
August 25, 2021
Study Record Updates
Last Update Posted (Actual)
June 27, 2025
Last Update Submitted That Met QC Criteria
June 23, 2025
Last Verified
June 1, 2025
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 21DI004
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
YES
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
Clinical Trials on Endovascular thrombectomy
-
Second Affiliated Hospital, School of Medicine,...Shanghai Zhongshan Hospital; The First People's Hospital of Huzhou; The Central... and other collaboratorsRecruitingStroke | Endovascular TherapyChina
-
Second Affiliated Hospital, School of Medicine,...RecruitingStroke, Acute Cerebral InfarctionChina
-
University of CalgaryMedtronic - MITG; Heart and Stroke Foundation of Canada; Hotchkiss Brain Institute...TerminatedIschemic StrokeCanada
-
Tianjin Huanhu HospitalRecruitingLarge Vessel Occlusion | Thrombectomy | Stroke Acute | Medical TreatmentChina
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingStroke | Ischemic Stroke | Endovascular ThrombectomyItaly
-
Feng GaoEnrolling by invitationAcute Basilar Artery Occlusion | Posterior Circulation Large InfarctChina
-
Hospital de Clinicas de Porto AlegreUniversity of Campinas, Brazil; Federal University of São Paulo; UPECLIN HC FM... and other collaboratorsUnknown
-
National Taiwan University HospitalRecruitingStroke, IschemicTaiwan
-
Yi YangNot yet recruitingAcute Ischemic Stroke From Large Vessel Occlusion | Endovascular ThrombectomyChina
-
Yonsei UniversityTerminatedAcute Ischemic StrokeKorea, Republic of